ARMONICA TECHNOLOGIES, INC.

ALBUQUERQUE, NM · Founded 2015 · Biotech · Private

High-throughput DNA sequencing platform using single-molecule Raman spectroscopy in coupled nanochannel/nanopore systems with metal-insulator-metal field enhancement

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Biotech
Headquarters
ALBUQUERQUE, NM
Founded
2015
Latest Form D
$4.2M, Dec 2025
Total capital
$9.3M
Federal grants
$2.2M
3 awards · 2021–2023
Rank in peer group#17 of 18
Private capital raised
$7M
3 Form D · last Dec 2025
11 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
2
18 pending · first 2023
Rank in peer group#4 of 18

Capital timeline

20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $9.3M$349K$944K$909K1st Form D$765K2nd Form D$2.1M3rd Form D$4.2M
20172019202120232025FEDERAL ↑EQUITY ↓Cumulative $9.3M$349K$944K$909K2nd Form D$2.1M3rd Form D$4.2M

Latest events

  • Private capital raisedForm D · SEC · 3rd filing$4.2M
  • Federal grantHealth and Human S · Phase II · Single molecule DNA/RNA sequencing technology based on a parallel Raman scattering readout in a coupled nanochannel/nanopore system$909K
  • Federal grantHealth and Human S · Phase II · Single molecule DNA/RNA sequencing technology based on a parallel Raman scattering readout in a coupled nanochannel/nanopore system$944K
  • Private capital raisedForm D · SEC · 2nd filing$2.1M
  • Federal grantHealth and Human S · Phase I · Single molecule DNA/RNA transport and Raman scattering readout in a coupled nanochannel/nanopore sequencing system.$349K
  • Private capital raisedForm D · SEC · 1st filing$765K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 18 peers

Line = median

Biotech · Device

  • Federal grantsBelow median
  • Granted patents#4 · top 22%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Steven R.J. BrueckResearcherDirectorLinked by $2.2M in grants as PI
  • Brian C. BirkDirectorNamed in SEC Form D filings
  • David BlivinDirectorNamed in SEC Form D filings
  • Emily MilsovicExecutive Officer, DirectorNamed in SEC Form D filings
  • Sally CorningDirectorNamed in SEC Form D filings
  • Scott L. GoldmanExecutive Officer, Director, PromoterNamed in SEC Form D filings
Show all 11 people
  • Stephen BrueckExecutive OfficerNamed in SEC Form D filings
  • Todd DickinsonDirectorNamed in SEC Form D filings
  • Victor EschExecutive Officer, DirectorNamed in SEC Form D filings
  • Waneta C. TuttleDirectorNamed in SEC Form D filings
  • Zachary R.J. LernerExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 20
  • PendingPolymer Sequencing Apparatus, Methods Of Fabrication And UseUSPTOApplication 19110571
  • PendingPolymer Sequencing Apparatus, Methods Of Fabrication And UseUSPTOApplication 19255351
  • PendingPolymer Sequencing Apparatus, Methods Of Fabrication And UseUSPTOApplication 19255376
Show all 20 patent records
  • Polymer Sequencing Apparatus, Methods Of Fabrication And UseJun 11, 2026 · Application 19110571Pending
  • Polymer Sequencing Apparatus, Methods Of Fabrication And UseMay 14, 2026 · Application 19255351Pending
  • Polymer Sequencing Apparatus, Methods Of Fabrication And UseMar 26, 2026 · Application 19255376Pending
  • Polymer Sequencing ApparatusJan 29, 2026 · Application 18998917Pending
  • Polymer Sequencing Apparatus, Methods Of Fabrication And UseOct 23, 2025 · Application 19255318Pending
  • Enhancement Structures For Surface-enhanced Raman ScatteringAug 15, 2024 · Application 18626970Pending
  • Enhancement Structures For Surface-enhanced Raman ScatteringMay 14, 2024 · US 11,982,626Granted
  • Manipulating The Translation Of Dna Strands Across And Through Nanopore Sequencing Systems Using Raman Signatures To Identify Dna Bases And MethodsNov 9, 2023 · Application 18132103Pending
  • Manipulating The Translation Of Dna Strands Across And Through Nanopore Sequencing Systems Using Raman Signatures To Identify Dna Bases And MethodsApr 11, 2023 · US 11,624,090Granted
  • Fabrication Of Double Resonance Surface Enhances Raman StructuresApplication 63168730Pending
  • Manufacturable Preparation Of Surface-enhanced Raman Scattering SubstratesApplication 63143431Pending
  • Manipulating The Translation Of Dna Strands Across And Through Nanopore Sequencing Systems Using Raman Signatures To Identify Dna Bases And MethodsApplication PCTUS2020013325Pending
  • Polymer Sequencing Apparatus, Methods And Fabrication And UseApplication PCTUS2025012979Pending
  • Apparatus, Integrated Fabrication and Method for Polymer SequencingApplication 63624403Pending
  • Polymer Sequencing ApparatusApplication PCTUS2023071183Pending
  • Nanochannel Approach To Dna SequencingApplication 63405801Pending
  • Nanochannel Approach To Dna SequencingApplication 63393130Pending
  • Enhancement Structures For Surface-enhanced Raman ScatteringApplication PCTUS2022014446Pending
  • Fabrication Of Double Resonance Surface Enhances Raman StructuresApplication 63280267Pending
  • Fabrication Of Double Resonance Surface Enhances Raman StructuresApplication 63191252Pending

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .